Circulating Galectin-3 in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction Treated with Mild Hypothermia: A Biomarker Sub-Study of the SHOCK-COOL Trial

Background: Galectin-3 (Gal-3) is considered a potential cardiovascular inflammatory marker that may provide additional risk stratification for patients with acute heart failure. It is unknown whether mild therapeutic hypothermia (MTH) impacts Gal-3 levels. Therefore, this biomarker study aimed to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Wenke, Fuernau, Georg, Desch, Steffen, Freund, Anne, Feistritzer, Hans-Josef, Pöss, Janine, Besler, Christian, Lurz, Philipp, Büttner, Petra, Thiele, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740246/
https://www.ncbi.nlm.nih.gov/pubmed/36498742
http://dx.doi.org/10.3390/jcm11237168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740246/
https://www.ncbi.nlm.nih.gov/pubmed/36498742
http://dx.doi.org/10.3390/jcm11237168

Ejemplares similares